Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|August 1, 1995
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusionG C Jayson, D Crowther, J Prendiville, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 1, 2010
Cross-visit tumor sub-segmentation and registration with outlier rejection for dynamic contrast-enhanced MRI time series dataG A Buonaccorsi, C J Rose, J P B O'Connor, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
Gynecologic Oncology|September 24, 2004
A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancerA Clamp, M Adams, R Atkinson, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|February 7, 2020
Dealing with loss: food and eating in women with ovarian cancer on parenteral nutritionA M Sowerbutts, S Lal, J Sremanakova, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancerA R Clamp, J Mäenpää, D Cruickshank, et al.
British Journal of Cancer|March 25, 2000
Requirement for expert histopathological assessment of ovarian cancer and borderline tumorsP S Sengupta, J H Shanks, C H Buckley, et al.
Veterinary Parasitology|May 1, 2012
Seroprevalence and isolation of Toxoplasma gondii from free-range chickens from Espírito Santo state, southeastern BrazilM A V Beltrame, H F J Pena, N C Ton, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancerA R Clamp, P Schöffski, J W Valle, et al.
Journal of Cancer Research and Clinical Oncology|October 27, 2005
Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factorM K Whitworth, A Sheen, D D Rosa, et al.
Pageof 7